Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3390/ijms18061273 http://scihub22266oqcxt.onion/10.3390/ijms18061273 C5486095!5486095!28617331     free     free     free       Int+J+Mol+Sci 2017 ; 18 (6): ä Nephropedia Template TP {{tp|p=28617331|t=2017. Hormesis and Defense of Infectious Disease |pdf=|usr=}}{{28617331}} gab.com Text Hormesis and Defense of Infectious Disease JO: Int J Mol Sci http://www.kidney.de/pget.php?&tw=1&pmid=28617331 #FOAvip Infectious diseases are a global health burden and remain associated with high social and economic impact. Treatment of affected patients largely relies on antimicrobial agents that act by directly targeting microbial replication. Despite the utility of host specific therapies having been assessed in previous clinical trials, such as targeting the immune response via modulating the cytokine release in sepsis, results have largely been frustrating and did not lead to the introduction of new therapeutic tools. In this article, we will discuss current evidence arguing that, by applying the concept of hormesis, already approved pharmacological agents could be used therapeutically to increase survival of patients with infectious disease via improving disease tolerance, a defense mechanism that decreases the extent of infection-associated tissue damage without directly targeting pathogenic microorganisms. Twit Text FOAVip Hormesis and Defense of Infectious Disease ????Int J Mol Sci http://www.kidney.de/pget.php?&tw=1&pmid=28617331 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28617331 #FOAvip English Wikipedia <ref>{{Cite pmid|28617331}}</ref> Hormesis and Defense of Infectious Disease #MMPMID28617331 Weis S; Rubio I; Ludwig K; Weigel C; Jentho E Int J Mol Sci 2017[Jun]; 18 (6): ä PMID28617331show ga Infectious diseases are a global health burden and remain associated with high social and economic impact. Treatment of affected patients largely relies on antimicrobial agents that act by directly targeting microbial replication. Despite the utility of host specific therapies having been assessed in previous clinical trials, such as targeting the immune response via modulating the cytokine release in sepsis, results have largely been frustrating and did not lead to the introduction of new therapeutic tools. In this article, we will discuss current evidence arguing that, by applying the concept of hormesis, already approved pharmacological agents could be used therapeutically to increase survival of patients with infectious disease via improving disease tolerance, a defense mechanism that decreases the extent of infection-associated tissue damage without directly targeting pathogenic microorganisms. äHormesis and Defense of Infectious Disease (epmc).pdf DeepDyve Pubget Overpricing